Civica Partners with U.S. Department of Veterans Affairs
Civica, a dedicated non-profit pharmaceutical company, has recently achieved a significant milestone by securing a contract from the U.S. Department of Veterans Affairs (VA). This partnership aims to deliver essential generic medications to the veterans this comprehensive healthcare system serves.
Commitment to Combating Drug Shortages
The initiative highlights Civica's commitment to addressing the ongoing issues of drug shortages in the U.S. healthcare system. The company was founded with the vision of mitigating the risks associated with a dwindling supply of generic drugs, an issue that has critically impacted the healthcare delivery system across the nation.
The Federal Supply Schedule (FSS) Program
Under the terms of the awarded Federal Supply Schedule (FSS) contract, Civica's essential medications will be made available via the VA’s Federal Supply Schedule Program. This program allows for streamlined access to these products at various VA medical centers and outpatient clinics, in addition to supporting other federal agencies, such as the Department of Defense (DoD).
Impact on Healthcare Facilities
The Veterans Health Administration (VHA), recognized as the largest integrated healthcare system in the country, encompasses an expansive network comprising 170 medical centers and 1,193 outpatient facilities. Civica’s partnership aims to reinforce the supply chain for crucial medications utilized within this extensive network, which caters to millions of veterans and their families.
Ensuring Quality and Affordability
Jennifer Spalding, the Chief Commercial Officer and General Counsel of Civica, expressed pride in the collaboration, emphasizing the importance of supplying essential medications to ensure a steady and safe supply for the VA’s various centers. This provision ultimately aims to safeguard the health of veterans and their families, ensuring they receive the care they deserve.
Tackling the Challenge of Drug Shortages
Drug shortages remain a pressing challenge for the U.S. healthcare industry, as reported by various organizations, including the American Society of Hospital Pharmacists. These shortages encompass numerous critical sterile injectables that are often pivotal in urgent care scenarios. Furthermore, when faced with shortages, hospitals must allocate additional resources—including time and personnel—to locate, procure, and administer alternative medications.
About Civica
Founded in 2018 by a group of innovative healthcare leaders, Civica is dedicated to ensuring the accessibility, affordability, and quality of essential generic medicines. The non-profit organization aims to stabilize the pharmaceutical market and minimize the effects of shortages, with a focus on producing more than 70 essential medications frequently listed in the FDA’s Drug Shortages Database. Serving over 1,400 hospitals, Civica currently impacts the care of over 90 million patients by committing to long-term contracts and maintaining a six-month safety stock of medications.
Contact Information and Media Inquiries
For media inquiries, please contact Liz Power, the Vice President of Communications. Civica encourages open communication, ensuring all inquiries are addressed promptly. Liz can be reached directly at 860 501 3849.
Frequently Asked Questions
What is Civica’s primary mission?
Civica aims to ensure the accessibility, affordability, and quality of essential generic medications.
What recent contract has Civica secured?
Civica has secured a contract with the U.S. Department of Veterans Affairs to supply essential generic medications.
How does Civica address drug shortages?
By committing to long-term contracts and maintaining a six-month safety stock of essential medicines to stabilize supplies.
Who benefits from Civica's medications?
More than 90 million patients across over 1,400 hospitals benefit from Civica's essential medications.
How can the media contact Civica?
The media can contact Liz Power, the Vice President of Communications, at 860 501 3849 for inquiries.